Accounts Receivable, after Allowance for Credit Loss, Current of Turnstone Biologics Corp. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Turnstone Biologics Corp. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
Turnstone Biologics Corp. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2024 was $0, a 100% decline year-over-year.
Source SEC data: View on sec.gov

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Turnstone Biologics Corp. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$0	-$194,000	-100%	31 Dec 2024	10-K	31 Mar 2025	2024	FY
Q3 2024	$0	-$217,000	-100%	30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q1 2024	$0			31 Mar 2024	10-Q	13 May 2024	2024	Q1
Q4 2023	$194,000	-$8,534,000	-98%	31 Dec 2023	10-K	31 Mar 2025	2024	FY
Q3 2023	$217,000			30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$250,000			30 Jun 2023	10-Q	01 Sep 2023	2023	Q2
Q4 2022	$8,728,000			31 Dec 2022	10-K	22 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.